Covered recipient · General Payments record
MICHAEL PEREZ MENDEZ
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$272,182.04
- Reported across 262 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $78,525.00 | 25 |
| Food and Beverage | $645.54 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Kedplasma LLC | $78,000.00 | 24 |
| CSL Plasma Inc. | $525.00 | 1 |
| ABBVIE INC. | $138.26 | 5 |
| AngioDynamics, Inc. | $136.65 | 1 |
| PFIZER INC. | $122.38 | 6 |
| Acerta Pharma LLC | $44.89 | 3 |
| Inspire Medical Systems, Inc. | $36.82 | 2 |
| Astellas Pharma US Inc | $36.64 | 2 |
| Otsuka America Pharmaceutical, Inc. | $32.74 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.41 | 1 |
| Paratek Pharmaceuticals, Inc. | $21.85 | 1 |
| Lundbeck LLC | $17.26 | 1 |
| DEXCOM, INC. | $14.74 | 1 |
| Amgen Inc. | $13.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (51)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $42.82 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105021300 | CMS |
| ABBVIE INC. | $17.22 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105021302 | CMS |
| ABBVIE INC. | $11.75 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105021304 | CMS |
| ABBVIE INC. | $46.56 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105021306 | CMS |
| ABBVIE INC. | $19.91 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105021308 | CMS |
| Amgen Inc. | $13.90 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117326609 | CMS |
| AngioDynamics, Inc. | $136.65 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095086963 | CMS |
| Astellas Pharma US Inc | $20.59 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139268062 | CMS |
| Astellas Pharma US Inc | $16.05 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139374403 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.68 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105514079 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.96 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105441522 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.25 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105667442 | CMS |
| CSL Plasma Inc. | $525.00 | 09/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142140264 | CMS |
| Dexcom, Inc. | $14.74 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153322400 | CMS |
| Inspire Medical Systems, Inc. | $20.33 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148082470 | CMS |
| Inspire Medical Systems, Inc. | $16.49 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148082474 | CMS |
| Kedplasma LLC | $3,500.25 | 01/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935051 | CMS |
| Kedplasma LLC | $2,999.75 | 01/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935053 | CMS |
| Kedplasma LLC | $3,500.25 | 02/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935055 | CMS |
| Kedplasma LLC | $2,999.75 | 02/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935057 | CMS |
| Kedplasma LLC | $3,500.25 | 03/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935059 | CMS |
| Kedplasma LLC | $2,999.75 | 03/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935061 | CMS |
| Kedplasma LLC | $3,500.25 | 04/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935063 | CMS |
| Kedplasma LLC | $2,999.75 | 04/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935065 | CMS |
| Kedplasma LLC | $3,500.25 | 05/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935067 | CMS |
| Kedplasma LLC | $2,999.75 | 05/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935069 | CMS |
| Kedplasma LLC | $3,250.00 | 06/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935071 | CMS |
| Kedplasma LLC | $3,250.00 | 06/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935073 | CMS |
| Kedplasma LLC | $3,250.00 | 07/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935075 | CMS |
| Kedplasma LLC | $3,250.00 | 07/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935077 | CMS |
| Kedplasma LLC | $3,250.00 | 08/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935079 | CMS |
| Kedplasma LLC | $3,250.00 | 08/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935081 | CMS |
| Kedplasma LLC | $3,250.00 | 09/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935083 | CMS |
| Kedplasma LLC | $3,250.00 | 09/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935085 | CMS |
| Kedplasma LLC | $3,250.00 | 10/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935087 | CMS |
| Kedplasma LLC | $3,250.00 | 10/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935089 | CMS |
| Kedplasma LLC | $3,250.00 | 11/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935091 | CMS |
| Kedplasma LLC | $3,250.00 | 11/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935093 | CMS |
| Kedplasma LLC | $3,250.00 | 12/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935095 | CMS |
| Kedplasma LLC | $3,250.00 | 12/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152935097 | CMS |
| Lundbeck LLC | $17.26 | 01/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145945784 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.76 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118941893 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.98 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118941895 | CMS |
| Paratek Pharmaceuticals, Inc. | $21.85 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113910308 | CMS |
| PFIZER INC. | $18.24 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130996343 | CMS |
| PFIZER INC. | $20.38 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131225345 | CMS |
| PFIZER INC. | $20.84 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131447370 | CMS |
| PFIZER INC. | $21.49 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131687174 | CMS |
| PFIZER INC. | $19.66 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131763866 | CMS |
| PFIZER INC. | $21.77 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131087133 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.41 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137634778 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.